BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3143430)

  • 41. Are aberrant BCR--ABL transcripts more common than previously thought?
    Wilson GA; Vandenberghe EA; Pollitt RC; Rees DC; Goodeve AC; Peake IR; Reilly JT
    Br J Haematol; 2000 Dec; 111(4):1109-11. PubMed ID: 11167748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia.
    Crisan D; Topalovski M; O'Malley B
    Diagn Mol Pathol; 1996 Dec; 5(4):236-48. PubMed ID: 8955614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
    Lemes A; Gómez Casares MT; de la Iglesia S; Matutes E; Molero MT
    Cancer Genet Cytogenet; 1999 Aug; 113(1):100-2. PubMed ID: 10459357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.
    Hochhaus A; Reiter A; Skladny H; Melo JV; Sick C; Berger U; Guo JQ; Arlinghaus RB; Hehlmann R; Goldman JM; Cross NC
    Blood; 1996 Sep; 88(6):2236-40. PubMed ID: 8822944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular diagnosis of the Philadelphia chromosome in chronic myelogenous and acute lymphoblastic leukemias by PCR.
    Maurer J; Kinzel H; Nentwig T; Thiel E
    Dis Markers; 1990; 8(4):211-8. PubMed ID: 2088636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic myelogenous leukemia: molecular and cellular aspects.
    Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
    J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.
    Ni H; Nitta M; Komatsu H; Kojima S; Suzuki S; Harada S; Tsuboi K; Banno S; Wakita A; Yazaki M; Ren L; Kato T; Ueda R
    Cancer Lett; 1998 Feb; 124(2):173-80. PubMed ID: 9500207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential display analysis of mRNAs in chronic myelogenous leukaemia.
    el-Awady MK; Abdalla NM; Salem AM; Samir S; Nour AM
    East Mediterr Health J; 2001; 7(4-5):707-15. PubMed ID: 15332769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of molecular techniques in the clinical management of leukemia. Lessons from the Philadelphia chromosome.
    Westbrook CA
    Cancer; 1992 Sep; 70(6 Suppl):1695-700. PubMed ID: 1516023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
    Skórski T; Szczylik C; Malaguarnera L; Calabretta B
    Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia.
    Chen Z; Hu S; Wang SA; Konopleva M; Tang Z; Xu J; Li S; Toruner G; Thakral B; Medeiros LJ; Tang G
    Leuk Lymphoma; 2020 Dec; 61(12):2831-2838. PubMed ID: 32700989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
    Huang W; Cao Q; Lu Y
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BCR-ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Aurer I; Butturini A; Gale RP
    Blood; 1991 Nov; 78(9):2407-10. PubMed ID: 1932752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
    Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
    Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Balanced parental contribution to the ABL component of the BCR-ABL gene in chronic myeloid leukemia.
    Melo JV; Yan XH; Diamond J; Goldman JM
    Leukemia; 1995 Apr; 9(4):734-9. PubMed ID: 7723412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia.
    Bock O; Reising D; Kreipe H
    Diagn Mol Pathol; 2003 Sep; 12(3):119-23. PubMed ID: 12960692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
    Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
    Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Futaki M; Dan K; Nomura T
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.